Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined intranasal steroid-mucolytic saline mixture versus fluticasone after FESS for chronic rhinosinusitis with nasal polyps
IRCT20191009045040N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of betamethasone, dexamethasone, bromhexine and fluticasone in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Age, Gender and 2 more. Started Dec 2022; status: completed.
02
Drugs
betamethasonedexamethasonebromhexinefluticasone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20191009045040N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191009045040N1.